Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing interferon alfa-2a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Interferon alfa-2a |
Inferred relationship |
Some |
1 |
Interferon-A-2a adverse reaction |
Causative agent |
True |
Interferon alfa-2a |
Inferred relationship |
Some |
1 |
Allergy to interferon alfa-2a (finding) |
Causative agent |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 6 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 9 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 12 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/0,6 ml injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 6 MIE/injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 9 MIE/injektionsvæske, opløsning, hætteglas a 0,9 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 36 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 3 MIE/injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/3 ml injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 3 MIE/injektionsvæske, opløsning, fyldt sprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
Interferon alfa-2a 6miu/vial injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
Peginterferon alfa-2a |
Is a |
False |
Interferon alfa-2a |
Inferred relationship |
Some |
|
Allergy to interferon alfa-2a (finding) |
Causative agent |
True |
Interferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing interferon alfa-2a in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Interferon alfa-2a |
Inferred relationship |
Some |
1 |
Interferon alfa-2a only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Interferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing only interferon alfa-2a in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Interferon alfa-2a |
Inferred relationship |
Some |
1 |
Peginterferon alfa-2a |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Interferon alfa-2a |
Inferred relationship |
Some |
|
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Interferon alfa-2a |
Inferred relationship |
Some |
1 |
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Interferon alfa-2a |
Inferred relationship |
Some |
1 |
Interferon alfa-2a (as peginterferon alfa-2a) 180 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Interferon alfa-2a |
Inferred relationship |
Some |
1 |